Related Experiment Video
Updated: Aug 5, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
In silico identification of selective cyclodecapeptide inhibitors targeting Plasmodium falciparum Grp78 chaperone
Wendy Mthembu1, Adeshina Odugbemi1, Florence Lisa Muzenda1
1Department of Biochemistry, Stellenbosch University, Stellenbosch, 7599, South Africa.
Abstract:
The increase in drug resistance by Plasmodium falciparum (Pf) remains a major challenge in eradicating malaria. The parasite drug resistance towards first line antimalarial therapy is associated with the parasite response to drug induced endoplasmic reticulum (ER) stress. The ER resident glucose-regulated protein 78 (PfGrp78) has been implicated as an ER stress response sensor. PfGrp78 binds to stressed protein substrates to suppress their misfolding and increase the capacity of the parasite ER to maintain proteostasis for parasite survival under stress. However, there have been limited efforts to target the parasite ER protein folding system as a potential drug target. This study sought to identify peptides that mimic the substrates of PfGrp78, which can be potential inhibitors of PfGrp78. Using the chaperone-substrate relationship, we explored the mechanism of action of cyclodecapeptides, gramicidin S (GS) and tyrocidines (Trcs), which were previously shown to exhibit potent antimalarial activity. In this study, using molecular docking and molecular dynamics simulation predictions, we observed that cyclodecapeptides bind to a unique site, suggesting preferential binding towards the substrate binding domain of PfGrp78 (β-SBD). The predicted binding site comprised the arch and pocket residues Gly426 to Thr446 and Pro455 to Val457, respectively. Furthermore, our extensive thermodynamics simulations supported the stable binding of the peptides and unveiled distinct inhibitory mechanisms. Our analysis suggests that the anti-plasmodial cyclodecapeptides, TrcA and GS, are predicted to act by inducing conformational locking, which may restrict the dynamic flexibility essential for the PfGrp78 chaperone cycle. Taken together, our results predict preferential binding of the cyclodecapeptides to PfGrp78 over its parasite cytosolic isoform and the human homologs. This offers promise for more experimental validation towards defining the molecular mechanism of action of these compounds.
Insights
Drug resistance in Plasmodium falciparum malaria is a major challenge. This study identifies cyclodecapeptides that inhibit PfGrp78, a key protein in parasite stress response, offering a new therapeutic strategy.
Area of Science:
- Biochemistry
- Parasitology
- Drug Discovery
Background:
- Plasmodium falciparum (Pf) drug resistance, particularly to first-line antimalarials, is a significant obstacle in malaria eradication.
- Parasite resistance is linked to the endoplasmic reticulum (ER) stress response, with ER-resident glucose-regulated protein 78 (PfGrp78) acting as a crucial sensor.
- Targeting the parasite's ER protein folding system presents a novel therapeutic avenue, yet remains underexplored.
Purpose of the Study:
- To identify peptides that mimic PfGrp78 substrates, serving as potential inhibitors of PfGrp78.
- To investigate the mechanism of action of cyclodecapeptides, gramicidin S (GS) and tyrocidines (Trcs), known for their antimalarial activity.
Main Methods:
- Utilized molecular docking and molecular dynamics simulations to predict binding interactions.
- Employed extensive thermodynamics simulations to analyze peptide binding stability and inhibitory mechanisms.
- Focused on the chaperone-substrate relationship to understand cyclodecapeptide action.
Main Results:
- Cyclodecapeptides were predicted to bind preferentially to the substrate binding domain (β-SBD) of PfGrp78.
- Specific binding sites involving residues Gly426-Thr446 and Pro455-Val457 were identified.
- Thermodynamics simulations confirmed stable peptide binding and revealed inhibitory mechanisms, including conformational locking that restricts PfGrp78's chaperone cycle.
Conclusions:
- Anti-plasmodial cyclodecapeptides, TrcA and GS, are predicted to inhibit PfGrp78 by inducing conformational locking.
- These compounds show preferential binding to PfGrp78 over its parasite cytosolic isoform and human homologs.
- The findings provide a basis for further experimental validation of these peptides as potential antimalarial agents targeting ER stress pathways.

